Aeterna Zentaris
AEZS
#10198
Rank
S$22.69 M
Marketcap
S$7.41
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Aeterna Zentaris (AEZS)

Earnings in 2024 (TTM): -S$7.38 Million

According to Aeterna Zentaris's latest financial reports the company's current earnings are S$6.32 Million. In 2023 the company made an earning of -S$4.34 Million a decrease over its 2022 earnings that were of S$4.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aeterna Zentaris from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$7.38 Million70.15%
2023 -S$4.34 Million-193.05%
2022 S$4.65 M118.42%
2021 S$2.13 M66.11%
2020 S$1.28 M-251.06%
2019 -S$0.86 Million25.51%
2018 -S$0.68 Million72.53%
2017 -S$0.4 Million-109.78%
2016 S$4.01 M49.97%
2015 S$2.67 M61.77%
2014 S$1.65 M597.94%
2013 S$0.23 M-134.11%
2012 -S$0.7 Million-182.25%
2011 S$0.84 M-50.2%
2010 S$1.69 M1084.23%
2009 S$0.14 M-109.18%
2008 -S$1.57 Million-6.23%
2007 -S$1.67 Million752.47%
2006 -S$0.2 Million269.03%
2005 -S$0.06 Million-84.64%
2004 -S$0.35 Million9.96%
2003 -S$0.32 Million184.21%
2002 -S$0.12 Million-69.93%
2001 -S$0.37 Million-22.76%
2000 -S$0.48 Million-13.94%
1999 -S$0.56 Million-31.33%
1998 -S$0.81 Million-84.12%
1997 -S$5.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-S$80.2 Million 1,028.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.27 B-299,416.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$10.40 B-146,540.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.79 B-165,996.94%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
S$0.96 B-13,698.38%๐Ÿ‡บ๐Ÿ‡ธ USA